Houston TX 间质性肺病临床试验
13项针对 间质性肺病的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
招募中3 期
- The University of Texas Health Science Center at Houston, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
招募中3 期
- GSK Investigational Site, Houston
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
招募中3 期
- Baylor College of Medicine, Houston
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
招募中2 期
- Baylor College of Medicine, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
招募中2 期
- Clinical Research Site, Houston
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
招募中
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中观察性研究
- Houston Methodist, Houston
- University of Texas Health Science Center at Houston, Houston
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
招募中观察性研究
- Baylor College of Medicine, Houston
- Houston Methodist Lung Center, Houston
- The University of Texas Health Science Center At Houston, Houston
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
招募中2 期
- Houston Methodist Hospital, Houston
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
招募中3 期
- Houston Methodist Outpatient Center, Houston
- The University of Texas Health Science Center at Houston, McGovern Medical School, Houston
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
招募中观察性研究
- Baylor College of Medicine/Texas Children'S Hospital, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
招募中2 期
- aTyr Investigative Site, Houston
其他城市的 间质性肺病试验
- New York City, NY18 项研究
- Philadelphia, PA16 项研究
- Los Angeles, CA15 项研究
- Kansas City, KS14 项研究
- Chicago, IL13 项研究
- Charleston, SC12 项研究
- Durham, NC12 项研究
- Aurora, CO11 项研究
- Ann Arbor, MI11 项研究
- Rochester, MN10 项研究
- Boston, MA10 项研究
- Birmingham, AL9 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症（所有类型）123 项研究
- 转移性癌症104 项研究
- 结直肠癌101 项研究
- 卵巢癌89 项研究
- 急性髓系白血病86 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌68 项研究
- 胰腺癌62 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月29日。每项研究自行设定入选标准，由研究团队决定谁能参与。